SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > All Processing News

Rondaxe launches drug manufacturing cost prediction tech for CMOs

11-Feb-2016 - Rondaxe Enterprises says CMOs can more accurately predict the cost of making customers drugs using its new software. 

Catalent Q2: Softgel growth blighted by Beinheim plant suspension

10-Feb-2016 - Suspension of operations at a French softgel facility reduced Catalent’s second quarter revenues by around $21m, but the firm expects full production to restart in March.

Shasun takes ‘Strides’ in Africa and Aus through double acquisition

08-Feb-2016 - Indian drugmaker Strides Shasun has bolstered its generics manufacturing network by acquiring stakes in Kenya’s Universal Corporation and Australia’s Generic Partners Holdings.

Dispatches from Cell Therapy Manufacturing & Gene Therapy Congress

Vendors must collaborate to develop cell therapy production automation, experts

04-Feb-2016 - Cell therapy development and production will not be sustainable unless there is a vendor-led shift to automated processes, said experts in Brussels yesterday.

Teva upskilling of UK sterile site could lead to loss of 80 jobs

03-Feb-2016 - Up to 80 UK sterile manufacturing jobs could be lost as part of a technical overhaul at a Teva site near Liverpool.

Reneuron gets US patent for non-toxic cell cryopreservation system

02-Feb-2016 - Reneuron has been granted a US patent for a cryopreservation technology that does not rely on toxic reagents and says it would consider licensing it to other stem cell therapy developers on a case-by-case basis.

Thawing market heats up: Biocision expands cell therapy tech offering

29-Jan-2016 - Biocision has revamped its cell thawing platform to accommodate larger vial sizes and started developing an automated system for cell therapies in cryopreservation bags.

Regulatory reforms to reshape drug manufacturing in China says expert

28-Jan-2016 - More plants in China will close says a US-based analyst who predicts that some drugmakers' inability to comply with stricter quality rules will create an opportunity for those that can.

Novartis: Centralised manufacturing unit will harness tech, not reduce network

28-Jan-2016 - Plans to centralise its manufacturing operations will optimise use of new technologies across Novartis’s divisions without resulting in any additional facility closures, the firm says.

Hermes adapts food coating technique for API taste masking

26-Jan-2016 - Hermes Pharma has added hot melt coating capabilities to its offering and hopes the food industry technique will win it pharma customers with unpleasant tasting APIs.

GSK biopharmaceutical trade secrets defendant still "at large"

26-Jan-2016 - Yan Mei, a defendant charged with stealing GlaxoSmithKline (GSK) trade secrets including biopharmaceutical manufacturing processes, remains at large, a spokesperson for the US Attourney's office told us yesterday.

Pfizer and Allergan to mull splitting up again in 2018 say CEOs

13-Jan-2016 - The Pfizer-Allergan $160bn merger will create the world’s largest pharma company but potentially not for long, as the two CEOs discuss breaking the entity up in 2018.

One by one: Continuous manufacturing gets broad support

12-Jan-2016 - Continuous manufacturing (CM) offers several benefits over traditional pharma manufacturing, including real-time monitoring, says expert.

Thermo Fisher to expand cellular analysis toolbelt in $1.3bn 'sensible' deal

12-Jan-2016 - Thermo Fisher will expand its antibody, multiplex RNA, and protein analysis tech offerings through the $1.3bn acquisition of Affymetrix.

Waters to open analytical lab in UK biohub

07-Jan-2016 - Waters Corporation will offer an open access analytical laboratory and technology support  to biotechs based at a former AstraZeneca site in the UK.

AstraZeneca's purple reign? Dr Reddy's relaunches Nexium generic in blue

06-Jan-2016 - Dr Reddy’s has changed the colour of its Nexium generic capsules from purple to blue in a bid to resume US sales, as litigation with AstraZeneca continues.

Paragon launches manufacturing compliance service for drug firms

05-Jan-2016 - Paragon Solutions has rolled out a new service to help drugmakers make sure their manufacturing operations comply with US FDA regulations.

B. Braun seeks World Bank loan to support construction of Indonesia parenterals plant

04-Jan-2016 - B. Braun has asked the World Bank for a €55m loan to support construction of a parenteral drug manufacturing facility it is building in Indonesia.

One MES to rule them all? LZ offers 'affordable' manufacturing software system

04-Jan-2016 - Software firm LZ Lifescience says small drugmakers could increase their productivity by over 25% by accessing Manufacturing Execution Systems (MESs) traditionally restricted to Big Pharma firms

Labelling survey reveals deep inefficiencies

21-Dec-2015 - Almost half of all manufacturers have reported production downtime resulting from barcode labelling problems, according to a new survey.

IPO ready BeiGene adopts GE tech for China cancer biologics plant

16-Dec-2015 - Nasdaq-bound Chinese biopharma BeiGene has chosen GE Healthcare’s Flexfactory platform for the monoclonal antibody (mAb) plant it is building in Suzhou.

AstraZeneca commits £75m to replace warehouse and packaging unit at UK plant

15-Dec-2015 - AstraZeneca has invested £75m ($114m) to build packaging and warehouse facilities at its manufacturing site in Macclesfield, UK.

Sun selling Ohio plant in post-Ranbaxy network restructure

15-Dec-2015 - Sun Pharma has announced it will divest a plant in Ohio to further consolidate manufacturing operations following its $4bn acquisition of Ranbaxy.

Protea and Agilent collaboration looks to address drug discovery and QA/QC

15-Dec-2015 - Protea Biosciences has teamed up with Agilent Technologies to offer drugmakers mass spectrometry alternatives to UV detection in QA/QC of recombinant proteins.

Dengvaxia approval vindicates €350m 'industrial risk' says Sanofi Pasteur

11-Dec-2015 - Sanofi Pasteur says Mexican approval for Dengvaxia vindicates the ‘industrial risk’ it took when it invested €350m in a dengue fever vaccine plant in 2009.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...